Showing results (161-170 of 696) with videos related to

Sort By:
Pageof 70
Primary Care Diabetes|October 22, 2022
Biochemical profiling, pharmacological management and clinical outcomes in type 2 diabetes in Danish primary care from 2001 to 2015Niels Søndergaard Heinrich, Margit Kriegbaum, Mia Klinten Grand, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2017
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal FunctionSergei Petrykiv, C David Sjöström, Peter J Greasley, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|July 7, 2011
Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemirKenichiro O'goshi, Jørgen Serup, Bente Blaaholm, et al.
Nephron|July 13, 2022
Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?Tobias Bomholt, Dea Kofod, Kirsten Nørgaard, et al.
Journal of the American Heart Association|June 20, 2019
Efficacy of Long-Term Remote Ischemic Conditioning on Vascular and Neuronal Function in Type 2 Diabetes Patients With Peripheral Arterial DiseaseChristian S Hansen, Marit E Jørgensen, Jesper Fleischer, et al.
Diabetologia|June 3, 2019
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 StudyPeter Gæde, Jens Oellgaard, Christina Kruuse, et al.
Diabetes Care|December 29, 2007
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
Redox Biology|July 1, 2017
Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes - A comparative study of two markers to identify high risk patientsKasper Broedbaek, Rasmus Køster-Rasmussen, Volkert Siersma, et al.
Blood Pressure Monitoring|July 9, 2015
Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetesEmilie H Petersen, Simone Theilade, Tine W Hansen, et al.
European Journal of Endocrinology|March 9, 2016
suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal diseaseSimone Theilade, Peter Rossing, Jesper Eugen-Olsen, et al.
Pageof 70